
Novo Nordisk’s Evolution: Navigating Growth and Challenges in the Global Healthcare Market
10 September 2025A Pharmaceutical Giant’s Journey Novo Nordisk has established itself as a global powerhouse, achieving $42 billion in sales last year, driven largely by the breakthrough success of its diabetes and obesity treatments Ozempic and Wegovy. Recent Developments and Challenges In a significant development, Novo Nordisk recently received accelerated approval from the U.S. FDA for Wegovy […]